Chloroquine and Its Derivatives Exacerbate B19V-Associated Anemia by Promoting Viral Replication

Abstract

Our data strongly suggest that 4-aminoquinoline drugs and their metabolites exacerbate B19V-associated anemia by promoting B19V replication. Consideration should be given for choosing a non-4-aminoquinoline drug to partner artemisinin compounds in combination antimalarial therapy.